Showing results (101-110 of 156) with videos related to
Sort By:
Pageof 16
Acta Oncologica (Stockholm, Sweden)|May 18, 2023
Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort studyLize Vanaken, F J Sherida H Woei-A-Jin, Rita Van Ginderdeuren, et al.Transplantation|September 17, 2020
Diagnostic Yield of 18F-FDG PET After Lung Transplantation: A Single-center, Retrospective Cohort StudyWinand Van Rompaey, Olivier Gheysens, Christophe M Deroose, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2013
18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacityEsther Wolfs, Tom Struys, Tineke Notelaers, et al.Urologic Oncology|February 7, 2015
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvementLaura Van den Bergh, Evelyne Lerut, Karin Haustermans, et al.Journal of Neuroendocrinology|April 6, 2026
European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoidsEric Baudin, Alice Durand, Wieneke Buikhuisen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2015
Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CTOlivier Gheysens, Andrey Postnov, Christophe M Deroose, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2020
Whole liver segmentation based on deep learning and manual adjustment for clinical use in SIRTXikai Tang, Esmaeel Jafargholi Rangraz, Walter Coudyzer, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 26, 2022
[18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patientsElin Pauwels, Sofie Celen, Kristof Baete, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2016
Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and ResectionCharlotte Billiet, Stéphanie Peeters, Herbert Decaluwé, et al.Nature Communications|November 3, 2017
MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitorsGiorgia Giacomazzi, Bryan Holvoet, Sander Trenson, et al.Pageof 16